STAT7d
FDA approves first xenotransplantation clinical trial, as United Therapeutics forges ahead
United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...
Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
FierceBiotech3d
eGenesis announces 2nd pig kidney procedure success, as xenotransplantation field moves forward
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
She's a medical miracle. Could her animal transplant success be just the beginning?
Towana Looney of Alabama is 'going strong and feeling great' after a pig kidney transplant. No one has lived longer with an ...
FDA approves pig organ transplant trials for patients with kidney failure
The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...
MedPage Today3d
First Gene-Edited Pig Kidney Functioned Until Recipient's Death
The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...